A study from earlier in October looked at the effectiveness of Moderna’s Covid-19 vaccine against infection and COVID-19 hospitalisation. This has been done many times before but this one looked specifically at effectiveness against SAR-CoV-2 Omicron subvariants.
Image credit: https://unsplash.com/es/@mili39
The study looked at a total of 123,236 individuals (30,809 positive cases and 92,427 negative cases). 12,724 (41.3%) positive cases where in the triple jabbed and 9,909 (32.2%) in the unvaccinated. There were 1,793 hospitalisations.
Whilst protection against hospitalisation (with 3 doses) was high, it reduced with each new Omicron variant. Furthermore, the authors say that vaccine efficacy against hospitalisation for BA.4/BA.5 could be particularly low for immunocompromised individuals.
So, the very people that need protection then.
However, the interesting results are those looking at efficacy against infection.
CONTINUE READING
https://nakedemperor.substack.com/p/pandemics-of-the-vaccinated